DLX-105
Product Specifications
Target
Interleukin|||TNF|||IFNAR
Related Pathways
Apoptosis|||Immunology/Inflammation
Bioactivity
DLX-105 is a human monoclonal antibody (mAb) that targets TNFSF2/TNFa. It reduces epidermal thickness and the expression of K16 and Ki67 in the skin. Additionally, DLX-105 downregulates mRNA levels of IL-17, TNF-?, IL-23p19, IL-12p40, and IFN-?. This compound is useful for psoriasis research.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/390881201931993229/T9901A-1696
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1193602-01 0.02 mg (E-Coli)
Recombinant Cyanothece sp. Translation initiation factor IF-3 (infC)
Ask
View Details MBS1193602-02 0.1 mg (E-Coli)
Recombinant Cyanothece sp. Translation initiation factor IF-3 (infC)
Ask
View Details MBS1193602-03 0.02 mg (Yeast)
Recombinant Cyanothece sp. Translation initiation factor IF-3 (infC)
Ask
View Details MBS1193602-04 0.1 mg (Yeast)
Recombinant Cyanothece sp. Translation initiation factor IF-3 (infC)
Ask
View Details